trending Market Intelligence /marketintelligence/en/news-insights/trending/b7m9imp4wlgcb3-d6ya3fq2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

More surgeons open to using robots; drugmakers get new targets for schizophrenia

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

More surgeons open to using robots; drugmakers get new targets for schizophrenia

Here are the editors' top picks for the week ended March 23.

Once questioned as science fiction, more surgeons becoming open to using robots

While a debate continues over the use of robots in hip and knee surgeries, proponents see signs that surgeons are increasingly accepting the technology.

Drugmakers target new approaches in drive to treat schizophrenia

There have been remarkably few advances in the treatments available for those diagnosed with schizophrenia in recent decades, but Cardiff University researchers have uncovered 50 new genes and brain pathways that increase the risk of developing it.

Sanofi, Regeneron, J&J drugs featured at US cardiology meeting

Regeneron Pharmaceuticals Inc. and Sanofi's cholesterol-lowering drug Praluent took center stage at the American College of Cardiology annual meeting in Orlando, Fla.

Trump says to expect 'beautiful' plan targeting high drug prices next month

President Donald Trump said he plans to roll out a detailed plan next month to lower U.S. drug prices.

Biomedical research, opioid crisis to get billions under 'omnibus' spending bill

House and Senate leaders have agreed to give the National Institutes of Health a $3 billion funding boost under the $1.3 trillion omnibus spending package unveiled late March 21.

House right-to-try experimental drugs bill succeeds on 2nd attempt

A bill to give critically ill patients greater access to experimental drugs beyond the U.S. Food and Drug Administration's current compassionate-use process succeeded in the House on the legislation's second attempt.

Capitol Checkup: CDC top job contender; 'gag' ban bills; force of nature lost

HIV/AIDS expert Robert Redfield is the top contender to lead the Centers for Disease Control and Prevention; two bills were introduced aimed at banning so-called gag clause practices, and a force of nature was lost on Capitol Hill.

Trump turns to 'toughness,' fear tactics to fight opioid crisis

The U.S. president said he plans to take "tough" measures to fight the epidemic, like seeking the death penalty for traffickers, building a wall to keep illicit substances out of the U.S. and launching ads to scare youngsters from trying the drugs.